Can we be so sure that the next generation of superdrug won't give rise to a comparable revolution in reducing risk? I'm not, and I work in the pharma industry.
True, I'm not especially upbeat about the prospects of jobs here or the survival of individual pharma companies (oft mismanaged, IMO). But I do believe major innovations are on the horizon and may have major impacts, bigger than the aforementioned statins.
Gene therapy, pluripotent cell line therapy, immune system driven therapy -- these all have stunning potential on a wide range of targets. Yes, the future of traditional small molecule drugs is cloudy. But the next generation of genomics and biologics may blow your socks off.
And even with antibiotics in specific, they save lives, but they also kill among the most people of any class of drug. They're a clear win if you're a burn victim or something, but most situations that are less acute either go away on their own or else were treated successfully with plant-based antibiotics. Despite what the pharma industry would have you believe, there's no law of the universe that decrees that fungi-based antiobiotics should be inherently more effective that plant-based antibiotics, the main reason the former are used today is just that they're less expensive to mass produce.
Tit for tat.
https://www.chemistryworld.com/news/antimicrobial-resistance...
https://www.theguardian.com/science/2016/mar/11/antibiotics-...
Although, why is my above post getting downvoted? Too cynical? I'm sorry. Next time I'll lie and say pharmaceutical industry is doing a splendid job and mother nature has taken second place and nobody is getting dementia from prostate medication.
Clearly, life is just roses and daisies here on HN.